Journal profile · Oncology
CA A Cancer Journal for Clinicians
ISSN 0007-9235 · eISSN 1542-4863 · Wiley-Blackwell · UNITED STATES · Bimonthly · Founded 1950
CA A Cancer Journal for Clinicians: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 671.5; fully open access; APC about USD 4,330; median 65 days to acceptance (38 articles, last 24 months); community-reported acceptance: about 50%; 80 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
CA A Cancer Journal for Clinicians is published by Wiley-Blackwell and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Advances in Oncology and Radiotherapy, Global Cancer Incidence and Screening and Cancer Treatment and Pharmacology, together about 29.2% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
From groundbreaking findings to insightful reviews, the American Cancer Society's family of journals continues to fuel new discoveries in cancer research and guide clinical practice around the world.
From the journal's Aims & Scope
Research area (LetPub): Oncology
Editor-in-chief Don S. DizonPublisher website
Editorial board by country: none in mainland China; most named United States 3 (3 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Advances in Oncology and RadiotherapyMedicine12.4%
- Global Cancer Incidence and ScreeningMedicine9.7%
- Cancer Treatment and PharmacologyMedicine7.1%
- BRCA gene mutations in cancerBiochemistry, Genetics and Molecular Biology7%
- Economic and Financial Impacts of CancerEconomics, Econometrics and Finance6.1%
- Cancer survivorship and careMedicine5.1%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology4.7%
- Colorectal Cancer Screening and DetectionMedicine4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Oncology | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Oncology | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Oncology | Zone 1 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 671.5LetPub ·
- CiteScore 2026-06
- 649.8LetPub ·
- SJR 2026-06
- 104.07LetPub ·
- SNIP 2026-06
- 152.11LetPub ·
- h-index
- 144LetPub ·
- h-index
- 270OpenAlex ·
- i10-index
- 1,275OpenAlex ·
- 2-year mean citedness
- 229.39OpenAlex ·
- Self-citation rate
- 0.2%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 32LetPub ·
- Articles per year (publisher) 2025
- 61Publisher website ·
- Downloads per year (publisher) 2025
- 4,041,925Publisher website ·
Articles by year OpenAlex count · 4,887 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 54 | 54 | 439 |
| 2025 | 80 | 80 | 3,945 |
| 2024 | 49 | 49 | 37,595 |
| 2023 | 56 | 56 | 23,165 |
| 2022 | 53 | 53 | 28,738 |
| 2021 | 57 | 57 | 140,172 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
65 daysMedian, submission to acceptance · P25–P75 41 days – 92 days
- Acceptance to online
- median 48 days (38 articles)
- Submission to online
- median 114 days
- Sample
- 38 articles with submission and acceptance dates (129 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 50%LetPub ·
- Acceptance rate (publisher)
- 31%Publisher website ·
- Acceptance rate (publisher) 2025
- 31%Publisher website ·
- Submission to first decision
- 2 daysPublisher website ·
- Submission to first decision 2025
- 2 daysPublisher website ·
- Submission to acceptance 2025
- 28 daysPublisher website ·
- Acceptance to publication 2025
- 39 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,330 / EUR 3,580 / GBP 2,900 | — | — | |
| Publisher website | Yes, amount not published | — | — |
Other charges and waivers (author guidelines)
- Colour charges
- No colour charges
- Page charges
- No page charges
- Submission fee
- No submission fee
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare7 items from the author guidelines
- Abstract
- ≤ 250 words
- Manuscript length
- ≤ 10,000 words
- Reference style
- Vancouver
- Suggested reviewers
- Optional
- Highlights
- Optional
- Graphical abstract
- Optional
- Not considered
- Case Reports; Letters to the Editor; systematic reviews; meta-analyses; statistics; Articles written with assistance from industry
Article types accepted14
- case reportMost CA articles are solicited reviews. With the exception of the American Cancer Society's Cancer Statistics articles, original research articles submitted for…Length not stated
- editorialMost CA articles are solicited reviews. With the exception of the American Cancer Society's Cancer Statistics articles, original research articles submitted for…Length not stated
- letters to the editorMost CA articles are solicited reviews. With the exception of the American Cancer Society's Cancer Statistics articles, original research articles submitted for…Length not stated
- meta-analysisMost CA articles are solicited reviews. With the exception of the American Cancer Society's Cancer Statistics articles, original research articles submitted for…Length not stated
- original research articleMost CA articles are solicited reviews. With the exception of the American Cancer Society's Cancer Statistics articles, original research articles submitted for…Length not stated
- patient pagesPatient Pages are written to provide general information on specific topics for patients and caregivers. Patient Pages are usually related to the content of the…Length not stated
- perspectiveMost CA articles are solicited reviews. With the exception of the American Cancer Society's Cancer Statistics articles, original research articles submitted for…Length not stated
- perspectives: research in contextPerspectives: Research in Context is a section designed specifically for busy clinicians. It features practical, concise information that is accompanied by insi…Length not stated
- phase iii randomized trialsPhase III Randomized Trials: CA is now accepting for consideration prospective high-impact randomized trials. Authors should submit a pre-submission query to th…Length not stated
- reviewMost CA articles are solicited reviews. With the exception of the American Cancer Society's Cancer Statistics articles, original research articles submitted for…Length not stated
- review articleMost CA articles are solicited reviews. With the exception of the American Cancer Society's Cancer Statistics articles, original research articles submitted for…Length not stated
- review articlesReview Articles: A timely, in-depth treatment of an issue. Review articles are generally solicited by the editors, but unsolicited materials will be considered.…Length not stated
- systematic reviewMost CA articles are solicited reviews. With the exception of the American Cancer Society's Cancer Statistics articles, original research articles submitted for…Length not stated
- virtual tumor boardVirtual Tumor Board: Solicited cases are featured to highlight multidisciplinary dialogue regarding complex therapeutic decisions for patients and their provide…Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Publication ethics, License & copyright, Peer review, Self-archiving
- Authorship Authorship
No submission, page, or color fees. Model summary
The journal follows the ICMJE definition of authorship, which indicates that authorship be based on the following 4 criteria:
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest
The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise, that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Poten…
Source ↗Publisher website ·- Publication ethics 5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS
Peer Review and AcceptanceAll submitted manuscripts are reviewed initially by the Editor for quality, scientific importance, and relevance to the journal’s general readership. Manuscripts with insufficient priority for publication or those that are outside the scope of the journal are rejected promptly. Manuscripts judged worthy of further consideration are sent to Associate Editors. Manuscripts t…
Source ↗Publisher website ·- License & copyright
Accepted papers published under CC-BY-NC-ND at no charge; APC applies for other CC licenses. Model summary
Accepted papers are published under a CC-BY-NC-ND Creative Commons license at no charge to the author.
Source ↗Publisher website ·- Peer review
Single-anonymous peer review; reviewer identities confidential, author identities known to reviewers. Model summary
CA employs a single-anonymous review process in which peer reviewer identities are kept confidential, but author identities are made known to reviewers.
Source ↗Publisher website ·- Self-archiving Embargo Policy
Once submitted, articles cannot be discussed with the media until one week before the publication date. Accepted articles are embargoed from reporting by all media until 12:01 A.M. (EST) on the date of online publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1950
- ISSN
- 0007-9235
- Electronic ISSN
- 1542-4863
- Latest issue on the website
- Volume 76, Issue 5 (October 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about CA A Cancer Journal for Clinicians
What CAS zone is CA A Cancer Journal for Clinicians in?
In the 2025 upgraded edition of the CAS Journal Ranking, CA A Cancer Journal for Clinicians is in Zone 1 of Medicine, and in Zone 1 of the minor category Oncology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of CA A Cancer Journal for Clinicians?
The latest impact factor listed by LetPub is 671.5; CiteScore 649.8, h-index 270.
How long does peer review take at CA A Cancer Journal for Clinicians?
Based on the dates recorded on 38 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 65 days (interquartile range 41–92 days); authors report an average review time of about 1 month; the community-reported acceptance is “about 50%”; the journal's website gives an acceptance rate of 31% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of CA A Cancer Journal for Clinicians?
According to the journal's author guidelines: Abstract: ≤ 250 words; Manuscript length: ≤ 10,000 words; Reference style: Vancouver; Suggested reviewers: Optional; Highlights: Optional; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of CA A Cancer Journal for Clinicians based?
Of the 3 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (3). Counted from the institutions listed on the board page; for reference only.
Which databases index CA A Cancer Journal for Clinicians?
According to LetPub and DOAJ records, CA A Cancer Journal for Clinicians is indexed in SCIE and Scopus.
Is CA A Cancer Journal for Clinicians open access, and what is the APC?
CA A Cancer Journal for Clinicians is a fully open-access journal. APC about USD 4,330.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .